Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ
Loading
Income Quality Over TimeExpanding
Percentile Rank83
3Y CAGR+3.5%
5Y CAGR+4.1%
Year-over-Year Change
Quality of reported income
3Y CAGR
+3.5%/yr
Annual compound
5Y CAGR
+4.1%/yr
Consistent
Percentile
P83
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 1.03 | +44.8% |
| 2023 | 0.71 | +3.0% |
| 2022 | 0.69 | -25.6% |
| 2021 | 0.93 | +26.7% |
| 2020 | 0.73 | -13.2% |
| 2019 | 0.84 | -18.5% |
| 2018 | 1.03 | - |